| Atiprimod |
Influence on protein activity |
Western Blot |
N/A µM |
SET-2 |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on protein activity |
Western Blot |
N/A µM |
SET-2 |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on protein activity |
Western Blot |
N/A µM |
SET-2 |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on protein activity |
Western Blot |
N/A µM |
CMK |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on protein activity |
Western Blot |
N/A µM |
CMK |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on protein activity |
Western Blot |
N/A µM |
CMK |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on protein activity |
Western Blot |
N/A µM |
SET-2 |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on protein activity |
Western Blot |
N/A µM |
SET-2 |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on protein activity |
Western Blot |
N/A µM |
SET-2 |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on protein activity |
Western Blot |
N/A µM |
CMK |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on protein activity |
Western Blot |
N/A µM |
CMK |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on protein activity |
Western Blot |
N/A µM |
CMK |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on patient derived cell proliferation |
MTS |
N/A µM |
expanded erythroid progenitor cells |
Homo sapiens |
patient material |
|
|
| Atiprimod |
Influence on protein-DNA interaction |
EMSA |
5.00 µM |
U266-B1 |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on protein-DNA interaction |
EMSA |
10.00 µM |
U266-B1 |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on protein-DNA interaction |
EMSA |
25.00 µM |
U266-B1 |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on protein-DNA interaction |
EMSA |
50.00 µM |
U266-B1 |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on protein activity |
Western Blot |
8.00 µM |
U266-B1 |
Homo sapiens |
|
p-STAT3 |
|
| Atiprimod |
Influence on protein activity |
Western Blot |
4.00 µM |
U266-B1 |
Homo sapiens |
|
p-STAT3 |
|
| Atiprimod |
Influence on protein activity |
Western Blot |
2.00 µM |
U266-B1 |
Homo sapiens |
|
p-STAT3 |
|
| Atiprimod |
Influence on protein activity |
Western Blot |
1.00 µM |
U266-B1 |
Homo sapiens |
|
p-STAT3 |
|
| Atiprimod |
Influence on protein activity |
Western Blot |
8.00 µM |
U266-B1 |
Homo sapiens |
|
STAT3 |
|
| Atiprimod |
Influence on protein activity |
Western Blot |
4.00 µM |
U266-B1 |
Homo sapiens |
|
STAT3 |
|
| Atiprimod |
Influence on protein activity |
Western Blot |
2.00 µM |
U266-B1 |
Homo sapiens |
|
STAT3 |
|
| Atiprimod |
Influence on protein activity |
Western Blot |
1.00 µM |
U266-B1 |
Homo sapiens |
|
STAT3 |
|
| Atiprimod |
Influence on protein activity |
Western Blot |
8.00 µM |
U266-B1 |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on protein activity |
Western Blot |
4.00 µM |
U266-B1 |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on protein activity |
Western Blot |
2.00 µM |
U266-B1 |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on protein activity |
Western Blot |
1.00 µM |
U266-B1 |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on protein-DNA interaction |
EMSA |
2.50 µM |
U266-B1 |
Homo sapiens |
|
STAT3 |
|
| Atiprimod |
Influence on protein activity in presence of IL-6 |
Western Blot |
2.50 µM |
MM-1 |
Homo sapiens |
|
p-STAT3 |
|
| Atiprimod |
Influence on protein activity in presence of IL-6 |
Western Blot |
2.50 µM |
MM-1 |
Homo sapiens |
|
STAT3 |
|
| Atiprimod |
Influence on protein activity in presence of IL-6 |
Western Blot |
2.50 µM |
MM-1 |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on cell viability |
MTT Assay |
2.00 µM |
MM-1 |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on cell viability |
MTT Assay |
4.00 µM |
MM-1 |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on cell viability |
MTT Assay |
6.00 µM |
MM-1 |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on cell viability |
MTT Assay |
8.00 µM |
MM-1 |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on cell viability |
MTT Assay |
2.00 µM |
U266-B1 |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on cell viability |
MTT Assay |
4.00 µM |
U266-B1 |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on cell viability |
MTT Assay |
6.00 µM |
U266-B1 |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on cell viability |
MTT Assay |
8.00 µM |
U266-B1 |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on cell viability |
MTT Assay |
2.00 µM |
OCI-MY5 |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on cell viability |
MTT Assay |
4.00 µM |
OCI-MY5 |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on cell viability |
MTT Assay |
6.00 µM |
OCI-MY5 |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on cell viability |
MTT Assay |
8.00 µM |
OCI-MY5 |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on cell viability |
MTT Assay |
2.00 µM |
MM-1R |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on cell viability |
MTT Assay |
4.00 µM |
MM-1R |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on cell viability |
MTT Assay |
6.00 µM |
MM-1R |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on cell viability |
MTT Assay |
8.00 µM |
MM-1R |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on cell viability |
MTT Assay |
2.00 µM |
RPMI-8266 |
Homo sapiens |
|
|
|
